Literature DB >> 7879246

Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients.

G Carrieri1, M L Jordan, R Shapiro, V P Scantlebury, C Vivas, S Kusne, M Magnone, J McCauley, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7879246      PMCID： PMC2950636     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

Authors:  H H Balfour; B A Chace; J T Stapleton; R L Simmons; D S Fryd
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

2.  Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.

Authors:  S A Plotkin; S E Starr; H M Friedman; K Brayman; S Harris; S Jackson; N B Tustin; R Grossman; D Dafoe; C Barker
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

3.  The cost impact of cytomegalovirus disease in renal transplant recipients.

Authors:  J M McCarthy; M A Karim; H Krueger; P A Keown
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

4.  A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients.

Authors:  M Martin; R Mañez; P Linden; D Estores; J Torre-Cisneros; S Kusne; L Ondick; R Ptachcinski; W Irish; D Kisor
Journal:  Transplantation       Date:  1994-10-15       Impact factor: 4.939

5.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

Authors:  N Singh; J S Dummer; S Kusne; M K Breinig; J A Armstrong; L Makowka; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

6.  The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.

Authors:  M L Smiley; C G Wlodaver; R A Grossman; C F Barker; L J Perloff; N B Tustin; S E Starr; S A Plotkin; H M Friedman
Journal:  Transplantation       Date:  1985-08       Impact factor: 4.939

7.  Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.

Authors:  M S Hirsch; R T Schooley; A B Cosimi; P S Russell; F L Delmonico; N E Tolkoff-Rubin; J T Herrin; K Cantell; M L Farrell; T R Rota; R H Rubin
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.